Moderna generates $18.4 billion in COVID vaccine sales in 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Moderna (MRNA) looking at pricing covid vaccine from $110-$130 per dose — WSJ
January 9, 2023 3:26 PM ESTModerna (NASDAQ: MRNA) is said to be evaluating pricing its Covid-19 vaccine between $110 to $130 per dose in the US once it moves from government contracting to commercial distribution, The Wall Street Journal reported Monday.
Moderna Chief Executive Officer Stephane Bancel was... More



